Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 8, 2025

Total Value ($000): $427,251 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 61.4%

Value ($000) $262,316 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 16.8%

Value ($000) $71,585 Shares 7,464,572 Est. Cost $13.72 Unrealized -59.7%

NAMS NEWAMSTERDAM PHARMA COMPANY 12.2%

Value ($000) $51,968 Shares 2,869,565 Est. Cost $10.96 Unrealized +66.5%

RAPT RAPT THERAPEUTICS INC 5.2%

Value ($000) $22,352 Shares 2,794,000 Est. Cost $7.63 Unrealized 0.0%

AURA AURA BIOSCIENCES INC 4.5%

Value ($000) $19,030 Shares 3,039,892 Est. Cost $17.87 Unrealized -67.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$262,316	61.4%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$71,585	16.8%	$13.72	-59.7%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$51,968	12.2%	$10.96	+66.5%	ORDINARY SHARES	N62509109
RAPT	RAPT THERAPEUTICS INC	2,794,000	$22,352	5.2%	$7.63	0.0%	COM	75382E208
AURA	AURA BIOSCIENCES INC	3,039,892	$19,030	4.5%	$17.87	-67.3%	COM	05153U107